Sign inGet started

Miljkovic Milos

Insider CIK 2000282 · RNAC Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RNAC Cartesian Therapeutics, In S Sale2026-01-062026-01-083,573$6.82 $24.4K58,820SEC↗
RNAC Cartesian Therapeutics, In A Award deriv2026-01-022026-01-0677,000— $077,000SEC↗
RNAC Cartesian Therapeutics, In A Award2026-01-022026-01-0627,000— $062,393SEC↗
RNAC Cartesian Therapeutics, In S Sale2025-01-062025-01-07948$16.83 $16.0K35,393SEC↗
RNAC Cartesian Therapeutics, In S Sale2025-01-032025-01-07932$16.72 $15.6K36,341SEC↗
RNAC Cartesian Therapeutics, In A Award deriv2025-01-022025-01-0656,000— $056,000SEC↗
RNAC Cartesian Therapeutics, In A Award2025-01-022025-01-0619,000— $037,273SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2024-11-152024-11-1820,000— $030,528SEC↗
RNAC Cartesian Therapeutics, In M Exercise2024-11-152024-11-1820,000$3.23 $64.6K38,273SEC↗
RNAC Cartesian Therapeutics, In S Sale2024-11-152024-11-1820,000$17.14 $342.8K18,273SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2024-11-142024-11-1835,000— $050,528SEC↗
RNAC Cartesian Therapeutics, In M Exercise2024-11-142024-11-1835,000$3.23 $113.0K53,273SEC↗
RNAC Cartesian Therapeutics, In S Sale2024-11-142024-11-1835,000$16.13 $564.5K18,273SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2024-04-082024-04-1085,528— $085,528SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2024-04-082024-04-102,566— $00SEC↗
RNAC Cartesian Therapeutics, In A Award deriv2024-01-022024-01-04703,000— $0703,000SEC↗
RNAC Cartesian Therapeutics, In A Award2024-01-022024-01-04548,200— $0548,200SEC↗
RNAC Cartesian Therapeutics, In A Award deriv2023-11-132023-11-152,566— $02,566SEC↗